Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03190265
What this trial is testing

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 61
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934
What this trial is testing

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Who this might be right for
Gastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Daiichi Sankyo 490
Testing effectiveness (Phase 2)Active Not RecruitingNCT04543071
What this trial is testing

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasAdenocarcinoma
Columbia University 118
Testing effectiveness (Phase 2)Ended earlyNCT01248299
What this trial is testing

Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Centre Oscar Lambret 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT01053104
What this trial is testing

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Who this might be right for
Metastatic Colorectal CancerMetastatic Breast Cancer
University of Oxford 26
Testing effectiveness (Phase 2)Study completedNCT00806663
What this trial is testing

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Central European Society for Anticancer Drug Research 22
Not applicableStudy completedNCT07419516
What this trial is testing

MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.

Who this might be right for
Rectal Neoplasms
First Affiliated Hospital of Fujian Medical University 690
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)UnknownNCT01745107
What this trial is testing

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

Who this might be right for
Esophageal NeoplasmEsophageal Cancer TNM Staging Primary Tumor (T) T2Esophageal Cancer TNM Staging Primary Tumor (T) T3+2 more
Chinese Academy of Medical Sciences 240
Large-scale testing (Phase 3)Study completedNCT01550055
What this trial is testing

Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Zhangjiang Biotechnology Limited Company 512
Large-scale testing (Phase 3)Study completedNCT00677443
What this trial is testing

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Samsung Medical Center 344
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Testing effectiveness (Phase 2)Study completedNCT00078468
What this trial is testing

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

Who this might be right for
Colorectal Neoplasms
Pfizer 56
Testing effectiveness (Phase 2)Ended earlyNCT00102024
What this trial is testing

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal CancerMetastases
Biogen 30
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Testing effectiveness (Phase 2)UnknownNCT05965817
What this trial is testing

Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN

Who this might be right for
Colorectal CancerLiver Metastasis Colon CancerImage
Leiden University Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT00931840
What this trial is testing

EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Enzon Pharmaceuticals, Inc. 220
Next Page